Stories

Tue, 04 Aug 2026

Tue, 04 Aug 2026 Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025